RPG Life SciencesNSE:RPGLIFE -0.54%92 Dividend Yield % is 0.88% as of Jun. 27, 2026, which is 7% below its 10-year median of 0.95. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 92/100 and a GF Value™ of ₹2,359.83 (Fairly Valued). The stock has 3 warning signs investors should review. Among 516 Drug Manufacturers companies, RPG Life Sciences ranks worse than 74.22% on this metric.
As of today (2026-06-27), the Trailing Annual Dividend Yield of RPG Life Sciences is 0.88%.
The historical rank and industry rank for RPG Life Sciences's Dividend Yield % or its related term are showing as below:
NSE:RPGLIFE'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.31 Med: 0.95 Max: 3.58
Current: 0.88
During the past 13 years, the highest Dividend Yield of RPG Life Sciences was 3.58%. The lowest was 0.31%. And the median was 0.95%.
NSE:RPGLIFE's Dividend Yield % is ranked worse than 74.22% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs NSE:RPGLIFE: 0.88
During the past 12 months, RPG Life Sciences's average Dividends Per Share Growth Rate was 25.00% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 27.70% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of RPG Life Sciences was 44.20% per year. The lowest was -12.60% per year. And the median was 14.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
RPG Life Sciences (NSE:RPGLIFE) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
RPG Life Sciences Dividend Yield % Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Dividend Yield % falls into.
RPG Life Sciences (NSE:RPGLIFE) has a Dividend Yield % of 0.88% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on RPG Life Sciences and its competitors. This is near median its historical median of 0.95. Over the past decade, RPG Life Sciences' Dividend Yield % has ranged from 0.31 to 3.58. According to the industry distribution chart, RPG Life Sciences ranks #383 out of 516 companies in the Drug Manufacturers industry, placing it in the top 74.2%.
Is RPG Life Sciences' Dividend Yield % too high?
RPG Life Sciences' current Dividend Yield % of 0.88% is near median its 10-year median of 0.95. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 3.58. The Drug Manufacturers industry median Dividend Yield % is 2.03. RPG Life Sciences' value of 0.88% is 56.7% below this industry median. Based on the distribution chart, RPG Life Sciences ranks #383 out of 516 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, RPG Life Sciences has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Dividend Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #383 out of 516 companies for Dividend Yield %. This places RPG Life Sciences in the lower half of its industry. The industry median Dividend Yield % is 2.03. RPG Life Sciences' value of 0.88% is 56.7% below this benchmark. Historically, RPG Life Sciences' own Dividend Yield % has ranged from 0.31 to 3.58 over the past decade. While the company's 10-year median is 0.95 vs. the industry median of 2.03, RPG Life Sciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.03, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RPG Life Sciences's current Dividend Yield % of 0.88% is 56.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Dividend Yield % is 0.88%, which is near median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,359.83, compared to a current price of ₹2,276.40 — trading 3.5% below its estimated fair value. The current Dividend Yield % is 0.88%, which is near median its 10-year median of 0.95 and 56.7% below the Drug Manufacturers industry median of 2.03. RPG Life Sciences' overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Dividend Yield % is 0.88% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be undervalued.
The current stock price of ₹2,276.40 is trading 3.5% below its estimated GF Value™ of ₹2,359.83.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Dividend Yield %: 0.88% (near median its 10-year median of 0.95)
GF Value™: ₹2,359.83 vs. price of ₹2,276.40 (3.5% below fair value)
Industry Position: 56.7% below the Drug Manufacturers median (#383 of 516)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
92GF Score
Get the complete analysis for NSE:RPGLIFE
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
